ArticlePlastic and reconstructive surgery. Global open2025
Standardized 5-point Hyaluronic Acid Injection for the Correction of Lower Eyelid Bags: A Prospective Study.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The protrusion of lower eyelid bags is a common concern in aesthetic consultations, often contributing to a fatigued, aged appearance. Although surgical options exist, minimally invasive approaches such as hyaluronic acid injections have gained popularity. However, the infraorbital region remains challenging due to risks like malar edema. Methods: In this prospective observational study, patients were treated with a 5-point injection technique using 2 types of cohesive polydensified matrix hyaluronic acid fillers, administered in a supraperiosteal plane on days 0 and 30. Follow-up assessments were conducted at 30, 60, and 180 days, with a subset followed up for up to 16 months. Outcome evaluation included standardized photography, Vectra H2 imaging, and the Global Aesthetic Improvement Scale. Adverse events were monitored and treated according to clinical practice. Results: Twenty-six patients were treated. At 2 and 6 months posttreatment, 96.15% (25 of 26) reported satisfactory outcomes. In 5 (19.2%) patients, results were maintained at 16 months. Adverse events included ecchymoses and hematomas resolving within 2 weeks. Mild edema was common but subsided gradually within 60 days without intervention. One (3.85%) patient developed persistent edema requiring hyaluronidase. All adverse events were mild and nonserious. Conclusions: Five-point supraperiosteal hyaluronic acid injections seem to be a safe, well-tolerated nonsurgical option for correcting lower eyelid bags, providing sustained aesthetic outcomes in most patients. Anatomically guided techniques and rheologically adapted fillers may help minimize complications and enhance precision. Further research, ideally through controlled studies with independent evaluation, is recommended to confirm these findings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.